These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 12796539)
1. The clinical features of 16 cases of stroke associated with administration of IVIg. Caress JB; Cartwright MS; Donofrio PD; Peacock JE Neurology; 2003 Jun; 60(11):1822-4. PubMed ID: 12796539 [TBL] [Abstract][Full Text] [Related]
2. Strokes after intravenous gamma globulin: thrombotic phenomenon in patients with risk factors or just coincidence? Alexandrescu DT; Dutcher JP; Hughes JT; Kaplan J; Wiernik PH Am J Hematol; 2005 Mar; 78(3):216-20. PubMed ID: 15726606 [TBL] [Abstract][Full Text] [Related]
3. Neuropathologic findings in a Guillain-Barré patient with strokes after IVIg therapy. Byrne NP; Henry JC; Herrmann DN; Abdelhalim AN; Shrier DA; Francis CW; Powers JM Neurology; 2002 Aug; 59(3):458-61. PubMed ID: 12177388 [TBL] [Abstract][Full Text] [Related]
4. Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record. Dalakas MC; Clark WM Neurology; 2003 Jun; 60(11):1736-7. PubMed ID: 12796522 [No Abstract] [Full Text] [Related]
5. Treatment with rtPA of stroke associated with intravenous immunoglobulins perfusion. Fonseca AC; Geraldes R; Almeida V; Pinho e Melo T J Neurol Sci; 2011 Sep; 308(1-2):180-1. PubMed ID: 21665226 [TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature. Marie I; Maurey G; Hervé F; Hellot MF; Levesque H Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420 [TBL] [Abstract][Full Text] [Related]
7. Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders. Grillo JA; Gorson KC; Ropper AH; Lewis J; Weinstein R Neurology; 2001 Nov; 57(9):1699-701. PubMed ID: 11706114 [TBL] [Abstract][Full Text] [Related]
8. Thromboembolic complications of intravenous immunoglobulin treatment. Vucic S; Chong PS; Dawson KT; Cudkowicz M; Cros D Eur Neurol; 2004; 52(3):141-4. PubMed ID: 15479982 [TBL] [Abstract][Full Text] [Related]
9. Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases. Elkayam O; Paran D; Milo R; Davidovitz Y; Almoznino-Sarafian D; Zeltser D; Yaron M; Caspi D Ann Rheum Dis; 2000 Jan; 59(1):77-80. PubMed ID: 10627434 [TBL] [Abstract][Full Text] [Related]
10. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion. Barsheshet A; Marai I; Appel S; Zimlichman E Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446 [TBL] [Abstract][Full Text] [Related]
11. Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial. Harbo T; Andersen H; Hess A; Hansen K; Sindrup SH; Jakobsen J Eur J Neurol; 2009 May; 16(5):631-8. PubMed ID: 19236457 [TBL] [Abstract][Full Text] [Related]
12. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease. Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654 [TBL] [Abstract][Full Text] [Related]
14. Two young stroke patients associated with regular intravenous immunoglobulin (IVIg) therapy. Nakano Y; Hayashi T; Deguchi K; Sato K; Hishikawa N; Yamashita T; Ohta Y; Takao Y; Morio T; Abe K J Neurol Sci; 2016 Feb; 361():9-12. PubMed ID: 26810508 [TBL] [Abstract][Full Text] [Related]
15. Acute stroke with high-dose intravenous immune globulin. White DA; Leonard MC Am J Health Syst Pharm; 2007 Aug; 64(15):1611-4. PubMed ID: 17646563 [TBL] [Abstract][Full Text] [Related]
16. Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusions. Bichuetti-Silva DC; Furlan FP; Nobre FA; Pereira CT; Gonçalves TR; Gouveia-Pereira M; Rota R; Tavares L; Mazzucchelli JT; Costa-Carvalho BT Int Immunopharmacol; 2014 Dec; 23(2):442-6. PubMed ID: 25257732 [TBL] [Abstract][Full Text] [Related]
17. Not all intravenous immunoglobulin preparations are equally well tolerated. Feldmeyer L; Benden C; Haile SR; Boehler A; Speich R; French LE; Hofbauer GF Acta Derm Venereol; 2010 Sep; 90(5):494-7. PubMed ID: 20814625 [TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy. Ahsan N J Nephrol; 1998; 11(3):157-61. PubMed ID: 9650125 [TBL] [Abstract][Full Text] [Related]
19. Variations in serum hemoglobin, albumin, and electrolytes in patients receiving intravenous immunoglobulin therapy: a real clinical threat? Mignogna MD; Fortuna G; Ruoppo E; Adamo D; Leuci S; Fedele S Am J Clin Dermatol; 2007; 8(5):291-9. PubMed ID: 17902731 [TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature. Desborough MJ; Miller J; Thorpe SJ; Murphy MF; Misbah SA Transfus Med; 2014 Aug; 24(4):219-26. PubMed ID: 24164446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]